New rabies shot schedules tested in major 3,000-Person trial
⭐️ VACCINE ⭐️
Not yet recruiting
This large Phase 3 trial aims to find the best schedule for a preventive rabies vaccine. It will enroll 3,000 people aged 10-60 to compare the immune response and safety of five different vaccination timing plans. The study will measure antibody levels and track any side effects …
Phase: PHASE3 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:30 UTC